HOLD rating with $2.17 fair value vs $2.31 current price. Dominant ANZ position, 5.4% yield, but US expansion struggles and margin recovery challenges limit upside.
View noteQBE Insurance shows strong transformation with 18.2% ROE and 93.1% combined ratio, but fair value analysis suggests 54% overvaluation at current levels.
View noteDominant Australian airline trading at 38% discount with $19.04 fair value versus $11.89 current price, 20% EBITDA margins, 65% market share.
View noteMining services leader trading at 3.1x EV/EBITDA vs 9.0x peer median, fair value $3.92 vs current $2.02, strong execution track record
View noteFair value $3.62 vs current $1.94 (87% upside). Market-leading non-bank lender with 48.8% EBITDA margins, 12.1% ROIC, transforming to capital-light servicing model.
View noteTrading at 5.1x EBITDA vs peer median 12.5x, fair value $0.645 vs current $0.26 implies 148% upside through demographic tailwinds and platform integration.
View noteHOLD rating with $10.78 fair value vs $11.20 current price. Market leader with 25.8% share, 5.1% dividend yield, facing battery execution risks.
View noteOrora trades at A$1.89 versus A$2.38 fair value with 26% upside potential. Strong market positions offset by customer concentration risks and integration challenges.
View noteDevelopment-stage uranium leader with 3.10% ore grade advantage. Fair value $12.83 CAD vs current price, 82.7% projected EBITDA margins, binary regulatory catalyst November 2025.
View noteMining services contractor trading at $3.47 vs $5.96 fair value (72% upside). Strong order book visibility, conservative balance sheet, temporary OneSteel impacts clearing.
View noteMonopoly Rett syndrome treatment with 83.4% margins and A$222m cash. Fair value A$10.46 vs current A$16.93 suggests 62% overvaluation despite exceptional business quality.
View noteNick Scali trades at $19.37 vs fair value $18.34, reflecting 5.6% overvaluation. Strong ANZ market leadership with UK expansion catalyst requiring selective entry timing.
View note